Lung perfusion scans in ED patients with suspected pulmonary embolism
Official title: Evaluation of the Impact of Scintigraphy on Clinical Decision-Making and Patient Outcomes in Patients Undergoing Pulmonary Perfusion Scintigraphy and, When Required, Ventilation/Perfusion Scintigraphy for Suspected Pulmonary Embolism in the Emergency Department
Run by Antalya Health Sciences University · NCT07905781 · Data updated 2026-11-12
This study looks at how lung perfusion (and sometimes ventilation) scans in adults with suspected pulmonary embolism seen in the emergency department influence clinical decisions and patient outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Antalya Health Sciences University Academic / other |
| Locations | 1 site (Antalya, konyaaltı) |
| Status | Recruiting |
| Started | October 10, 2026 |
| Main results expected | January 1, 2027 |
| Study ends | February 1, 2027 |
| Registry record updated | October 29, 2026 |
| Trial ID | NCT07905781 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) evaluated for suspected pulmonary embolism in the ED at Antalya Training and Research Hospital who completed a pulmonary perfusion scintigraphy (with or without ventilation scintigraphy) and have complete records for the required variables.
✕Probably not a fit
Patients with incomplete records or those scanned for indications other than suspected pulmonary embolism may not benefit from the study findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center, retrospective observational study using routinely collected electronic health records from Antalya Training and Research Hospital. The researchers will identify adults evaluated for suspected pulmonary embolism who underwent pulmonary perfusion scintigraphy, with or without ventilation scintigraphy, from January 1, 2019 to the ethics approval date. They will review how scan results correlated with decisions such as starting or stopping anticoagulation, requesting additional imaging, and hospital disposition, as well as patient flow metrics like ED and hospital length of stay, ICU admission, return ED visits, and 30-day mortality. Imaging findings will be categorized by the original nuclear medicine reports and management changes will be assessed from documented diagnostic assessments, anticoagulation decisions, and disposition notes. All data are from routine clinical care and no experimental interventions are performed.
Why it matters
Potential benefit: If successful, the study could clarify how perfusion and ventilation scan results guide real-world decision-making in suspected PE, potentially informing more efficient care pathways.
How similar studies have gone: Previous work using retrospective imaging data has shown that scintigraphy findings can influence management, but this study adds real-world ED decision-making context in a single center.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older at the index emergency department visit. * Evaluation for suspected pulmonary embolism at Antalya Training and Research Hospital during the study period. * Completion of pulmonary perfusion scintigraphy, with or without additional ventilation scintigraphy, for suspected pulmonary embolism. * Availability of medical records containing the demographic, clinical, imaging, and outcome information required for the study. Exclusion Criteria: * Scintigraphy performed for an indication other than suspected pulmonary embolism. * Scintigraphy requested by a department other than the emergency department. * Scintigraphy requested but not completed. * Unavailable scintigraphy reports or essential clinical records. * Unavailable essential outcome information, including emergency department disposition, hospitalization, intensive care admission, or mortality status. * Duplicate records relating to the same clinical episode. Separate episodes involving a new evaluation for suspected pulmonary embolism may be included as distinct clinical episodes.
Where it's running
-
University of Health Sciences, Antalya Training and Research Hospital
Antalya, konyaaltı, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: murat Duyan, ASSOCIATE PROFESSOR
- Email: drmuratduyan@gmail.com
- Phone: +905401561989
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Thromboelastometry to Predict Thrombosis and Survival in Glial Tumor Surgery
Aimed at people with glial tumors undergoing surgery, the study tests whether thromboelastometry and other blood tests can predict blood-clot risk and survival.
-
Non-contrast CT V: See If CT has a Role in Finding Pulmonary Embolism
This study tests whether additional low-dose, non-contrast CT scans can help detect pulmonary embolism in patients who are already being evaluated for suspected PE.
-
Screening for blood clots in adults with acute heart failure
This trial tests whether a guideline-based screening approach can detect pulmonary embolism in adults admitted with acute heart failure.
-
Repeated exams to classify early pulmonary embolism
This project will test whether doing repeated blood tests, ECGs, and bedside heart ultrasounds during the first 48 hours after pulmonary embolism helps predict who will get worse in adults treated at Sahlgrenska University Hospital.
-
Best time for reperfusion in acute pulmonary embolism
This study will test whether performing reperfusion (systemic thrombolysis or catheter‑directed therapy) earlier improves survival and reduces complications in adults with high‑risk or intermediate‑high‑risk pulmonary embolism.
-
Inorganic nitrates for intermediate high-risk pulmonary embolism
This test gives nitrate-rich beetroot juice to see if lowering lung artery pressure helps people with intermediate high‑risk pulmonary embolism who have signs of right‑heart strain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.